RMD (STOCKS)
ResMed Inc.
$192.740000
-2.040000 (-1.05%)
Prev close: $194.780000
Company Information
- Exchange
- XNYS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Michael J. Farrell
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $27,960.35M
- Employees
- 10,600
- P/E (TTM)
- 18.78
- P/B (TTM)
- 4.35
- Dividend Yield
- 123.22%
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
4
Strong Buy
11
Buy
8
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q3)
|
$2.86 | $2.82 | +0.0362 | +1.28% |
|
Dec 2025 (Q2)
|
$2.81 | $2.75 | +0.0591 | +2.15% |
|
Sep 2025 (Q1)
|
$2.55 | $2.58 | -0.0299 | -1.16% |
|
Sep 2000 (Q1)
|
$0.05 | $0.04 | +0.0071 | +16.55% |
Financial Statements
| Revenues | $5.54B |
| Benefits Costs and Expenses | $3.63B |
| Cost Of Revenue | $2.13B |
| Costs And Expenses | $3.63B |
| Gross Profit | $3.41B |
| Nonoperating Income/Loss | $10.76M |
| Operating Expenses | $1.52B |
| Selling, General, and Administrative Expenses | $1.09B |
| Research and Development | $359.00M |
| Other Operating Expenses | $70.67M |
| Operating Income/Loss | $1.89B |
| Income/Loss Before Equity Method Investments | $1.90B |
| Income/Loss From Continuing Operations After Tax | $1.52B |
| Income/Loss From Continuing Operations Before Tax | $1.90B |
| Income/Loss From Equity Method Investments | $5.99M |
| Income Tax Expense/Benefit | $383.74M |
| Net Income/Loss | $1.52B |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $1.52B |
| Net Income/Loss Available To Common Stockholders, Basic | $1.52B |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $10.41 |
| Diluted Earnings Per Share | $10.37 |
| Basic Average Shares | 145,713,000 |
| Diluted Average Shares | 146,277,000 |
| Assets | $8.78B |
| Current Assets | $4.06B |
| Inventory | $911.88M |
| Other Current Assets | $3.15B |
| Noncurrent Assets | $4.72B |
| Fixed Assets | $566.97M |
| Other Non-current Assets | $4.15B |
| Liabilities | $2.29B |
| Current Liabilities | $1.35B |
| Accounts Payable | $273.30M |
| Other Current Liabilities | $1.08B |
| Noncurrent Liabilities | $941.16M |
| Long-term Debt | $404.17M |
| Other Non-current Liabilities | $537.00M |
| Equity | $6.49B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $6.49B |
| Liabilities And Equity | $8.78B |
| Net Cash Flow From Operating Activities | $1.89B |
| Net Cash Flow From Operating Activities, Continuing | $1.89B |
| Net Cash Flow From Investing Activities | -$295.26M |
| Net Cash Flow From Investing Activities, Continuing | -$295.26M |
| Net Cash Flow From Financing Activities | -$907.75M |
| Net Cash Flow From Financing Activities, Continuing | -$907.75M |
| Exchange Gains/Losses | $40.85M |
| Net Cash Flow | $727.80M |
| Net Cash Flow, Continuing | $686.95M |
| Comprehensive Income/Loss | $1.75B |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $1.75B |
| Other Comprehensive Income/Loss | $344.79M |